CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Cronos expects CanAdelaar acquisition to close in second half of 2026 as Q2 adjusted EBITDA reaches $13.1M

Neutral
AI Analysis

Summary

Cronos Group expects to close its acquisition of CanAdelaar in the second half of 2026, with Q2 adjusted EBITDA reaching $13.1M.

Outcome Details

Acquisition expected to close in second half of 2026

Importance:6/10
Sentiment:
0.20
acquisitionM&AEBITDA
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 6, 2026 6:16 PM

Read Original